These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2150411)

  • 21. [Antibiotic susceptibility of Staphylococcus aureus strains isolated in two university hospitals in Rabat, Morocco].
    Elhamzaoui S; Benouda A; Allali F; Abouqual R; Elouennass M
    Med Mal Infect; 2009 Dec; 39(12):891-5. PubMed ID: 19269758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can we control the spread of antibiotic-resistant nosocomial pathogens? The methicillin-resistant Staphylococcus aureus paradigm.
    Struelens MJ; Denis O
    Curr Opin Infect Dis; 2006 Aug; 19(4):321-2. PubMed ID: 16804377
    [No Abstract]   [Full Text] [Related]  

  • 23. Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit.
    Ju O; Woolley M; Gordon D
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):61-2. PubMed ID: 16331332
    [No Abstract]   [Full Text] [Related]  

  • 24. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
    Aepfelbacher M
    MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multi-resistant S. aureus--MRSA].
    Hauer T; Daschner F
    Internist (Berl); 1998 Oct; 39(10):1074-5. PubMed ID: 9827381
    [No Abstract]   [Full Text] [Related]  

  • 26. Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus.
    Rehm SJ; Tice A
    Clin Infect Dis; 2010 Sep; 51 Suppl 2():S176-82. PubMed ID: 20731575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals--a report update from the Canadian Nosocomial Infection Surveillance Program.
    Can Commun Dis Rep; 2005 Feb; 31(3):33-40. PubMed ID: 15693179
    [No Abstract]   [Full Text] [Related]  

  • 28. Methicillin-resistant Staphylococcus aureus (mrsa) in a Malaysian hospital.
    Cheong I; Tan SC; Wong YH; Zainudin BM; Rahman MZ
    Med J Malaysia; 1994 Mar; 49(1):24-8. PubMed ID: 8057986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Methicillin-resistant Staphylococcus aureus (MRSA) -- therapy and hygienic measures].
    Linde H; Lehn N
    Dtsch Med Wochenschr; 2005 Mar; 130(11):586-8; quiz 589-92. PubMed ID: 15761788
    [No Abstract]   [Full Text] [Related]  

  • 31. [Methicillin resistant Staphylococcus aureus].
    Shimada K
    Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):436-40. PubMed ID: 1607813
    [No Abstract]   [Full Text] [Related]  

  • 32. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An analysis of patient characteristics for methicillin-resistant Staphylococcus aureus colonization and infection in a hospital population.
    Archbald CD; Powers JS; Burger MC; Dixon R; Hall A
    J Tenn Med Assoc; 1993 Mar; 86(3):102-4. PubMed ID: 8445905
    [No Abstract]   [Full Text] [Related]  

  • 34. [Methicillin resistant staphylococcus aureus (MRSA): incidence is growing in French-speaking Switzerland].
    Blanc DS; Troillet N; Siegrist HH; Fracheboud D; Petignat C; Francioli P
    Rev Med Suisse Romande; 2001 Apr; 121(4):309-12. PubMed ID: 11400404
    [No Abstract]   [Full Text] [Related]  

  • 35. Methicillin-resistant staphylococci: a sign of the times?
    McDonald PJ
    Med J Aust; 1982 May; 1(11):445-6. PubMed ID: 7099073
    [No Abstract]   [Full Text] [Related]  

  • 36. No mercy for MRSA: treatment alternatives to vancomycin and linezolid.
    Wegner DL
    MLO Med Lab Obs; 2005 Jan; 37(1):26-9. PubMed ID: 15743145
    [No Abstract]   [Full Text] [Related]  

  • 37. Methicillin-resistant Staphylococcus aureus: an evolving clinical challenge.
    Karchmer AW; Bayer AS
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S342-3. PubMed ID: 18462088
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro combined bactericidal activity of cefpirome and glycopeptides against glycopeptides and oxacillin-resistant staphylococci.
    Bergeret M; Boutros N; Raymond J
    Int J Antimicrob Agents; 2004 Mar; 23(3):247-53. PubMed ID: 15164965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link?
    Falcone M; Giannella M; Raponi G; Mancini C; Venditti M
    Clin Microbiol Infect; 2006 Jan; 12(1):96-7. PubMed ID: 16460556
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular epidemiology of methicillin-resistant Staphylococcus aureus in a Tokyo hospital in 2001.
    Fujino T; Mori N; Kawana A; Naiki Y; Kawahata H; Kuratsuji T; Kudo K; Kobori O; Yazaki Y; Kirikae T
    Jpn J Infect Dis; 2001 Dec; 54(6):240-2. PubMed ID: 11862007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.